Does Losartan reduce the severity of COVID-19 in hypertensive patients?

Overview of attention for article published in BMC Cardiovascular Disorders, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#45 of 1,928)
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 2 news outlets

twitter: 21 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 18 Mendeley

Summary News X Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Reply to: RAAS inhibitors in COVID-19: Not all are created equal!

Article in Revista Portuguesa de Cardiologia (June 2023)

Structure-Based Virtual Screening and Functional Validation of Potential Hit Molecules Targeting the SARS-CoV-2 Main Protease

Article in Biomolecules (November 2022)

Clinical protocol for early treatment of COVID-19 in a real-world scenario: Results of a series of patients

Article in Medicina Clínica Práctica (September 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.